Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Neurim
Neurim v. Mylan-- the Illiad was shorter Neurim v. Mylan-- the Illiad was shorter Reviewed by Frantzeska Papadopoulou on Tuesday, February 01, 2022 Rating: 5
The Swedish Patent and Market Court of Appeal applies "Abraxis" in rejecting Supplementary Protection Certificate The Swedish Patent and Market Court of Appeal applies "Abraxis" in rejecting Supplementary Protection Certificate Reviewed by Frantzeska Papadopoulou on Wednesday, February 26, 2020 Rating: 5
BREAKING: CJEU delivers another blow to SPC owners in Abraxis Article 3(d) (or 1(b)) battle BREAKING: CJEU delivers another blow to SPC owners in Abraxis Article 3(d) (or 1(b)) battle Reviewed by Annsley Merelle Ward on Thursday, March 21, 2019 Rating: 5
The Opinion of the Advocate General in the case C-443/17 (Abraxis case). A lost case for second medical indication SPCs? The Opinion of the Advocate General in the case C-443/17 (Abraxis case). A lost case for second medical indication SPCs? Reviewed by Frantzeska Papadopoulou on Sunday, December 23, 2018 Rating: 5
Introducing the AdvoKat: Does Neurim represent an important development in SPC jurisprudence? Introducing the AdvoKat: Does Neurim represent an important development in SPC jurisprudence? Reviewed by Annsley Merelle Ward on Friday, July 20, 2012 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.